Position in ZTS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$38,187,481
+$13,057,690 QoQ
Shares Held
531,415
+150.0% QoQ
Ownership
0.129%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#107
of 1,412 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Gotham Asset Management, LLC holds $248,215,917 across 22 Drug Manufacturers - Specialty & Generic names. ZTS ranks #4 (15.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
4,374,683 | $69,469,966 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
371,568 | $62,624,070 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
79,123 | $42,871,215 | |
| 4 | ZTS |
Zoetis Inc.
This page
|
531,415 | $38,187,481 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
465,714 | $11,461,221 | |
| 6 | PRGO |
PERRIGO Co plc
|
435,648 | $4,526,382 | |
| 7 | INDV |
Indivior Pharmaceuticals, Inc.
|
94,850 | $3,891,695 | |
| 8 | COLL |
Collegium Pharmaceutical, Inc
|
76,441 | $2,767,164 |
All Filings in ZTS
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $38,187,481 | 531,415 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $25,129,791 | 212,586 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $12,268,330 | 97,507 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $10,944,882 | 74,801 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $8,768,600 | 56,227 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $2,952,503 | 17,932 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,299,040 | 7,973 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $775,853 | 3,971 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $441,201 | 2,545 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,133,707 | 6,700 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $397,700 | 2,015 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $308,466 | 1,773 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $2,055,842 | 11,938 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,430,052 | 8,592 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $2,888,207 | 19,708 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $2,974,549 | 20,059 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,864,031 | 16,662 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $4,065,434 | 21,557 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $791,877 | 3,245 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,156,491 | 5,957 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $2,052,009 | 11,011 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $3,675,898 | 23,342 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $4,246,399 | 25,658 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $2,942,759 | 17,795 | Shares | Sole | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||